Reflections on NICE’s Uptake of New Methods: Past, Present, and the 2020 Review Meindert BoysenIan Watson Commentary 04 February 2020 Pages: 243 - 245
After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator? Mark SculpherStephen Palmer Current Opinion 13 January 2020 Pages: 247 - 257
Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study Elisabet JacobsenDwayne BoyersAlison Avenell Practical Application Open access 13 January 2020 Pages: 259 - 267
Multi-criteria Decision Analysis Software in Healthcare Priority Setting: A Systematic Review Alexander Moreno-CalderónThai S. TongPraveen Thokala Systematic Review 10 December 2019 Pages: 269 - 283
Potential Bias Associated with Modeling the Effectiveness of Healthcare Interventions in Reducing Mortality Using an Overall Hazard Ratio Fernando Alarid-EscuderoKaren M. Kuntz Original Research Article 22 November 2019 Pages: 285 - 296
Healthcare Expenditures for the Treatment of Patients Infected with Hepatitis C Virus in Japan Haruhisa FukudaYoshihiko YanoOsamu Takahashi Original Research Article 25 November 2019 Pages: 297 - 306
Economic Impact of Early-in-Hospital Diagnosis and Initiation of Eculizumab in Atypical Haemolytic Uraemic Syndrome Michael RyanBonnie M. K. DonatoJeffrey Laurence Original Research Article Open access 12 December 2019 Pages: 307 - 313
Correction to: The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes Laura PanattoniPaul M. BrownPatrick Gladding Correction 21 January 2020 Pages: 315 - 315
